While most of the MNCs are looking at destination India to drive top line growth with India-centric strategies ranging from branded generics to therapy focused dominance, the Indian companies too are gearing up by tapping new markets, launching novel combinations, strengthening the brand building activities, opening up multiple divisions for better management of portfolio, investing in larger field force sizes for incremental reach & penetration and devising innovative strategies to accelerate the growth rates further.